Media Center Banner

IMPaCT Investigator Highlights

Bernard Kwabi-Addo, Ph.D.
Howard University
The Role of DNA Methylation in Prostate Cancer Health Disparity
Dr. Kwabi-Addo's Poster

Tomasz Beer, M.D.; Elisabeth I. Heath, M.D.; Celestia S. Higano, M.D.; Howard I. Scher, M.D.
Oregon Health and Sciences University
Karmanos Cancer Institute Wayne State University
University of Washington Fred Hutchinson Cancer Research
Sidney Kimmel Center for Prostate and Urologic Cancers Memorial Sloan-Kettering
Prostate Cancer Clinical Trials Consortium: Bringing the "Best of the Best" to Prostate Cancer Patients

Robert K. Bright, Ph.D.
Texas Tech University
Prostate Cancer Vaccines Targeting Over-Expressed Self-Oncoantigens

Arul M. Chinnaiyan, M.D., Ph.D.
University of Michigan Medical School
Therapeutic Targeting of SPINK-1-Positive Prostate Cancer

Scott Dehm, Ph.D.
Masonic Cancer Center of the University of Minnesota
Androgen Receptor and Castration-Resistant Prostate Cancer

Samuel R. Denmeade, M.D.
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
Prostate-Specific Membrane Antigen Activated Prodrug and Imaging Agents
Dr. Denmeade's Poster

Phillip Febbo, M.D.
University of California, San Franscisco, Mt. Zion Medical Center
Increased P38 MAPK Is Responsible for Docetaxel Resistance in Prostate Cancer

Paul Godley, M.D., Ph.D.
University of North Carolina and at Shaw University
Shaw-UNC Undergraduate Program in Prostate Cancer Research and Training
Dr. Godley's Poster

Evan T. Keller, D.V.M., Ph.D.
University of Michigan
Novel Application of Aptamer Selection (Pheno-SELEX) to Target the Invasive Phenotype Successfully Creates Anti-Metastatic Aptamers

Richard J. Lee, M.D., Ph.D.
Massachusetts General Hospital Cancer Center
Analysis of Circulating Prostate Cancer Tumor Cells Using the CTC-Chip Microfluidic Device
Dr. Lee's Poster

David M. Lubaroff, Ph.D.; Kaylene Baugh
University of Iowa
Lincoln University
Undergraduate Program in Prostate Cancer Research and Training
Dr. Lubaroff and Baugh's Poster

Lorelei Mucci, M.P.H., Sc.D.
Harvard School of Public Health
Defining Gleason Grade as a Predictor of Lethal Prostate Cancer
Dr. Mucci's Poster

Isaac J. Powell, M.D., F.A.C.S.
Wayne State University and Karmanos Cancer Institute
The Influence of Metabolic Syndrome on Prostate Cancer Progression and Risk of Recurrence in African-American and European-American Men
Dr. Powell's Poster

R. Renee Reams, Ph.D.
College of Pharmacy & Pharmaceutical Sciences, Florida A&M University
Genomics of Prostate Cancer Health Disparity

Marianne Sadar, Ph.D.
British Columbia Cancer Agency
Regression of Castrate-Recurrent Prostate Cancer by Antagonists to the Androgen Receptor N-Terminal Domain

Susan F. Slovin, M.D., Ph.D.
Memorial Sloan-Kettering Cancer Center
PSMA - Target T Cells for the Treatment of Castrate Metastatic Prostate Cancer
Dr. Slovin's Poster

Vasan Yegnasubramanian, M.D., Ph.D.
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
Integrative Analysis of Genetic and Epigenetic Alterations in Lethal Metastatic Prostate Cancer
Dr. Yegnasubramanian's Poster